We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed 19/09/2025) YEMEX fentanyl 50 microgram/hour transdermal patch (UK)
Section 19A approved medicine
(Approval lapsed 19/09/2025) YEMEX fentanyl 50 microgram/hour transdermal patch (UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Lapsed
Medicines in short supply/unavailable
DUROGESIC fentanyl 50 micrograms/h transdermal patch sachet - ARTG 112369
DENPAX fentanyl 50 micrograms/hour transdermal patch - ARTG 163064
DENPAX fentanyl 50 micrograms/hour transdermal patch - ARTG 163064
Indication(s)
For the management of pain associated with cancer, palliative care, and other conditions in patients where:
- other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and
- the pain is opioid-responsive, and
- severe enough to require daily, continuous, long term opioid treatment.
Not for use in opioid-naive patients.
Images
